AQR Arbitrage’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

AQR Arbitrage’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,417,879	Closed	-$26.5M	–	1620
2022 Q1	$26.5M	Buy	1,417,879 +1,024,838	+261%	+$18.4M	0.69%	32
2021 Q4	$8.41M	Buy	+393,041	New	+$7.74M	0.21%	114
2021 Q2	–	Sell	-62,667	Closed	-$1.21M	–	1333
2021 Q1	$1.21M	Buy	+62,667	New	+$1.1M	0.04%	333

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AQR Arbitrage's OCDX Position: Q2 2022 in Review

AQR Arbitrage sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 1,417,879 shares — an estimated $26.5M sold.

AQR Arbitrage first reported a position in OCDX in Q1 2021 and held it in 3 quarters. The position peaked at $26.5M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

AQR Arbitrage reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
AQR Arbitrage sold 1,417,879 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $26.5M.
AQR Arbitrage first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 3 quarters.
AQR Arbitrage's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $26.5M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on AQR Arbitrage's 13F filing for Q2 2022, filed 15 Aug 2022.